The FDA classification underscores the urgency of the situation and the potential danger posed by the contaminated products.
Certain people risk severe or life-threatening reactions if they consume these products, according to an official alert.
FDA commissioner Marty Makary revealed at the 2026 CES trade show in Las Vegas that low-risk devices will face less ...
The U.S. Food and Drug Administration says it will ease regulatory requirements for certain consumer wearable health devices.
The U.S. Food and Drug Administration said on Tuesday that it will limit regulation of wearable devices and software designed ...
The Food and Drug Administration (FDA) updated its guidance on Tuesday to allow more wearables to fall into a general ...
FDA nonmedical wearable health data devices providing general health info will not face regulation, clarifying guidance for ...
The FDA will ease regulation of digital health products, aiming to deregulate AI and promote its widespread use.
Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...
CTx001 has previously received FDA IND clearance and will be evaluated in Opti-GAIN, a first-in-human Phase I/II clinical trial MUNICH, Jan. 8, 2026 /PRNewswire/ -- Complement Therapeutics GmbH (CTx), ...
The US Food and Drug Administration has missed its latest deadline to propose banning formaldehyde and certain ...
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...